Full video transcriptClick to expand
Auto-generated transcript of @jacobnach's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Welcome back to trying and see you on half too.
- 0:01If you don't know me, I've treated my body like a lab rat
- 0:04for the last 10 years of my life.
- 0:05And I'm going over everything I've taken affects my body.
- 0:08Today's episode is SS-31.
- 0:09I've been using SS-31 for the last couple of weeks
- 0:11and I would recommend this peptide to anyone
- 0:13who's an athlete, entrepreneur, business person,
- 0:16or anyone who feels like they're burning the candle
- 0:18at both ends.
- 0:18For me, I run a nationwide telemedicine company
- 0:20but I'm also trying to get as jacked as humanly possible
- 0:22without blasting gear.
- 0:23On the business side, the number one thing I noticed
- 0:25is burnout just left my body.
- 0:26Which is a little different than the way I use C-Max
- 0:28or NAD+, which helped improve my focus.
- 0:31This isn't making the focus stronger.
- 0:32It's making the focus longer.
- 0:34For me, I would get that wired but tired feeling.
- 0:36Where during the day, you can't wait to go to bed
- 0:38and then as soon as you get into bed, you can't fall asleep.
- 0:39That completely flipped where I was focused during the day
- 0:42and then at night, I was ready to knock out.
- 0:43A lot of times I'm working 10, 12 hour days
- 0:45and then going to work out.
- 0:46And on the athletic side, the number one benefit I noticed,
- 0:48HRV and VO2 max.
- 0:50Imagine your body's like a toy car.
- 0:51The mitochondria, the little batteries, the power of the car.
- 0:54Every time you send a text or handle a meeting
- 0:56or go work out, you're burning the batteries.
- 0:57My SS-31 has been finally finding the charger to the batteries.
- 1:00Pretty much only positives with this peptide on my next go.
- 1:03I'm gonna try and mix it with some others I've seen work well.
- 1:05But on my first go, I'm rating my experience
- 1:07with this peptide in 8.8.
Peptide 'hidden gems': separating real data from bro-science
Quick answer
SS-31 (elamipretide) is an investigational mitochondria-targeting peptide with published human data primarily in cardiovascular disease populations, not healthy adults. The creator's claims about burnout resolution, improved HRV, and enhanced VO2 max in an athletic context have no direct clinical trial support, though the underlying mitochondrial mechanism is scientifically plausible. Self-administration of unregulated compounded peptides carries unknown long-term safety risks that are not addressed in the video.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 5 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Peptide 'hidden gems': separating real data from bro-science, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Peptide 'hidden gems': separating real data from bro-science is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Peptide 'hidden gems': separating real data from bro-science" from Jacob Nach. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: SS-31 (elamipretide) is an investigational mitochondria-targeting peptide with published human data primarily in cardiovascular disease populations, not healthy adults.
The reason this review is not generic is the source wording and the canonical claim label "peptides this peptide is the hidden gem most peptide gurus coaches or." In this clip, the useful excerpt is: "Welcome back to trying and see you on half too." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against NAD+ metabolism and its roles in cellular processes during ageing (2021), Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women (2021), and Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults (2018), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
SS-31 (elamipretide) is an investigational mitochondria-targeting peptide with published human data primarily in cardiovascular disease populations, not healthy adults.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- SS-31 (elamipretide) is an investigational mitochondria-targeting peptide with published human data primarily in cardiovascular disease populations, not healthy adults. The creator's claims about burnout resolution, improved HRV, and enhanced VO2 max in an athletic context have no direct clinical trial support, though the underlying mitochondrial mechanism is scientifically plausible. Self-administration of unregulated compounded peptides carries unknown long-term safety risks that are not addressed in the video.
- SS-31 has a real and published mechanism: it binds cardiolipin in the inner mitochondrial membrane to reduce oxidative stress (Szeto, 2014, Journal of Cardiovascular Pharmacology).
- The only published human performance data comes from heart failure patients, not healthy athletes. Daubert et al. (2017, JACC: Heart Failure) found improved exercise tolerance in HFpEF, a diseased population.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- SS-31 has a real and published mechanism: it binds cardiolipin in the inner mitochondrial membrane to reduce oxidative stress (Szeto, 2014, Journal of Cardiovascular Pharmacology).
- The only published human performance data comes from heart failure patients, not healthy athletes. Daubert et al. (2017, JACC: Heart Failure) found improved exercise tolerance in HFpEF, a diseased population.
- No clinical trials have studied SS-31 for burnout, sleep normalization, HRV improvement, or VO2 max in healthy adults. These are plausible hypotheses, not proven outcomes.
- SS-31 (elamipretide) is not FDA-approved for any indication. It is an investigational compound and compounded versions carry real quality control risks including unknown concentration and contamination.
- Self-experimentation over a few weeks without controls cannot isolate a peptide's effects from placebo response, lifestyle changes, or normal biological variation.
- Injection-site reactions have been reported in clinical trials. The creator's 'pretty much only positives' framing does not reflect the full known side-effect profile.
- Anyone seriously considering SS-31 should consult a licensed medical provider. It should not be sourced or used based on social media testimonials, regardless of the quality of the presenter's reasoning.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @jacobnach actually say?
The creator describes SS-31 as a "hidden gem" peptide he's been using for a few weeks, rating his personal experience an 8.8 out of 10. His core claims: SS-31 eliminated his burnout, converted his "wired but tired" sleep pattern into proper day-night energy cycling, and improved both his HRV and VO2 max. He frames the mitochondria as "little batteries" and SS-31 as "finding the charger." He's not claiming a cure for anything. He's logging a personal biohack experiment, which is exactly how this should be framed, and largely is.
He also draws a distinction between SS-31 and other compounds he uses: Semax and NAD+ sharpen focus, while SS-31 "makes the focus longer." That's a more specific, and honestly more interesting, claim than the usual peptide hype. Whether it holds up scientifically is a different question.
Does the science back this up?
Partially. SS-31 (also known as elamipretide) has real preclinical and some clinical data behind it, mostly in the context of serious disease, not athletic optimization. The mitochondria angle is legitimate science. SS-31 targets cardiolipin, a phospholipid in the inner mitochondrial membrane, and has been shown to reduce oxidative stress and improve mitochondrial efficiency in animal models and human heart failure trials.
Szeto (2014, Journal of Cardiovascular Pharmacology) established the cardiolipin-binding mechanism. Dai et al. (2013, Archives of Biochemistry and Biophysics) showed improved mitochondrial function in aged mouse hearts. A Phase 2 trial by Daubert et al. (2017, JACC: Heart Failure) found improved exercise tolerance in patients with heart failure with preserved ejection fraction, which is the closest thing to a real human performance signal in the literature.
The HRV and VO2 max claims in healthy athletes? No published human trials there. The burnout and sleep normalization claims? Zero direct evidence. Plausible mechanism, missing data.
What did they get wrong (or right)?
The mitochondria-as-batteries analogy is reductive but not wrong. SS-31 does work at the mitochondrial level, and mitochondrial dysfunction does contribute to fatigue. Credit where it's due.
What's missing is the dose-response context. Every SS-31 human trial has used subcutaneous injection in specific patient populations, typically cardiovascular disease. Healthy adults self-administering unregulated peptide products are operating in a completely different context, and the creator glosses over that entirely. The "pretty much only positives" line is a red flag. In serious trials, SS-31 has shown injection-site reactions and the long-term safety profile in healthy humans is simply unknown.
The specific claim that SS-31 flipped his "wired but tired" pattern is unverifiable at the individual level, and almost certainly involves confounding variables, sleep hygiene, workload changes, placebo response. Attributing a behavioral change to a peptide after a few weeks without controls is a common and understandable error in self-experimentation. It's not evidence.
What should you actually know?
SS-31 is one of the more scientifically grounded peptides in the biohacking space, which is a low bar but still meaningful. The mechanism is real. The preclinical data is real. Some human data exists, though in sick populations, not healthy athletes.
The gap between "this compound improves mitochondrial function in heart failure patients" and "this will fix your burnout and boost your VO2 max" is significant. It's not a leap you can make on the current evidence. The creator is honest that this is personal experimentation, which is the appropriate framing. But 26,000 viewers are watching this as a buying guide, not a lab notebook.
Regulatory status matters too. SS-31/elamipretide is an investigational compound. It is not FDA-approved. Compounded peptide products sourced outside licensed pharmacy channels carry real quality control risks including contamination, incorrect concentration, and undisclosed additives. Anyone considering this compound should be doing so under medical supervision with a legitimate prescription, not based on a TikTok rating of 8.8.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Jacob Nach · TikTok creator
26.7K views on this video
This peptide is the hidden gem, most “peptide gurus” “coaches” or “doctors” probably haven’t used it but I try all here’s my take
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about ss-31 has a real?
SS-31 has a real and published mechanism: it binds cardiolipin in the inner mitochondrial membrane to reduce oxidative stress (Szeto, 2014, Journal of Cardiovascular Pharmacology).
What does the video say about the only published human performance data comes from heart failure?
The only published human performance data comes from heart failure patients, not healthy athletes. Daubert et al. (2017, JACC: Heart Failure) found improved exercise tolerance in HFpEF, a diseased population.
What does the video say about no clinical trials have studied ss-31 for burnout, sleep normalization,?
No clinical trials have studied SS-31 for burnout, sleep normalization, HRV improvement, or VO2 max in healthy adults. These are plausible hypotheses, not proven outcomes.
What does the video say about ss-31 (elamipretide)?
SS-31 (elamipretide) is not FDA-approved for any indication. It is an investigational compound and compounded versions carry real quality control risks including unknown concentration and contamination.
What does the video say about self-experimentation over a few weeks without controls cannot?
Self-experimentation over a few weeks without controls cannot isolate a peptide's effects from placebo response, lifestyle changes, or normal biological variation.
What does the video say about injection-site reactions have been reported in clinical trials. the creator's?
Injection-site reactions have been reported in clinical trials. The creator's 'pretty much only positives' framing does not reflect the full known side-effect profile.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Jacob Nach, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.